364 related articles for article (PubMed ID: 25920907)
1. Medicines taken by older Australians after transient ischaemic attack or ischaemic stroke: a retrospective database study.
Sluggett JK; Caughey GE; Ward MB; Gilbert AL
Int J Clin Pharm; 2015 Oct; 37(5):782-9. PubMed ID: 25920907
[TBL] [Abstract][Full Text] [Related]
2. Use of secondary stroke prevention medicines in Australia: national trends, 2003-2009.
Sluggett JK; Caughey GE; Ward MB; Gilbert AL
Med J Aust; 2014 Jul; 201(1):54-7. PubMed ID: 24999900
[TBL] [Abstract][Full Text] [Related]
3. Sociodemographic factors are associated with utilisation of statins after ischaemic stroke/TIA.
Geary L; Aronius J; Wettermark B; Hasselström J; Sjöborg B; von Euler M
Int J Clin Pract; 2017 Mar; 71(3-4):. PubMed ID: 28371022
[TBL] [Abstract][Full Text] [Related]
4. Secondary-prevention drug prescription in the very elderly after ischemic stroke or TIA.
Ovbiagele B; Hills NK; Saver JL; Johnston SC
Neurology; 2006 Feb; 66(3):313-8. PubMed ID: 16476928
[TBL] [Abstract][Full Text] [Related]
5. Recording a diagnosis of stroke, transient ischaemic attack or myocardial infarction in primary healthcare and the association with dispensation of secondary preventive medication: a registry-based prospective cohort study.
Dahlgren C; Geary L; Hasselström J; Rehnberg C; Schenck-Gustafsson K; Wändell P; Euler MV
BMJ Open; 2017 Sep; 7(9):e015723. PubMed ID: 28939569
[TBL] [Abstract][Full Text] [Related]
6. Antithrombotic use following transient ischaemic attack or ischaemic stroke among older Australians with atrial fibrillation.
Sluggett JK; Caughey GE; Ward MB; Gilbert AL
Intern Med J; 2014 Nov; 44(11):1134-7. PubMed ID: 25367727
[TBL] [Abstract][Full Text] [Related]
7. Under-prescribing of Prevention Drugs and Primary Prevention of Stroke and Transient Ischaemic Attack in UK General Practice: A Retrospective Analysis.
Turner GM; Calvert M; Feltham MG; Ryan R; Fitzmaurice D; Cheng KK; Marshall T
PLoS Med; 2016 Nov; 13(11):e1002169. PubMed ID: 27846215
[TBL] [Abstract][Full Text] [Related]
8. Transient ischaemic attack and ischaemic stroke: constructing episodes of care using hospital claims data.
Sluggett JK; Caughey GE; Ward MB; Roughead EE; Gilbert AL
BMC Res Notes; 2013 Apr; 6():128. PubMed ID: 23547772
[TBL] [Abstract][Full Text] [Related]
9. [Characteristics and prevention among patients with stroke: a study of 36,844 patients hospitalized in France].
Tuppin P; Moysan V; de Peretti C; Schnitzler A; Fery-Lemonnier E; Woimant F
Rev Neurol (Paris); 2013 Feb; 169(2):126-35. PubMed ID: 22749335
[TBL] [Abstract][Full Text] [Related]
10. Quality of secondary prevention measures in TIA patients: a retrospective cohort study.
Lager KE; Wilson A; Khunti K; Mistri AK
Postgrad Med J; 2012 Jun; 88(1040):305-11. PubMed ID: 22434914
[TBL] [Abstract][Full Text] [Related]
11. Greater Adherence to Secondary Prevention Medications Improves Survival After Stroke or Transient Ischemic Attack: A Linked Registry Study.
Dalli LL; Kim J; Cadilhac DA; Greenland M; Sanfilippo FM; Andrew NE; Thrift AG; Grimley R; Lindley RI; Sundararajan V; Crompton DE; Lannin NA; Anderson CS; Whiley L; Kilkenny MF
Stroke; 2021 Nov; 52(11):3569-3577. PubMed ID: 34315251
[TBL] [Abstract][Full Text] [Related]
12. Use of medications for secondary prevention in stroke patients at hospital discharge in Australia.
Eissa A; Krass I; Bajorek BV
Int J Clin Pharm; 2014 Apr; 36(2):384-93. PubMed ID: 24519632
[TBL] [Abstract][Full Text] [Related]
13. First hospitalization for transient ischemic attack in France: Characteristics, treatments and 3-year outcomes.
Cosker K; Samson S; Fagot-Campagna A; Woimant F; Tuppin P
Rev Neurol (Paris); 2016 Feb; 172(2):152-9. PubMed ID: 26318894
[TBL] [Abstract][Full Text] [Related]
14. Initiation of oral anticoagulation after acute ischaemic stroke or transient ischaemic attack: timing and complications of overlapping heparin or conventional treatment.
Audebert HJ; Schenk B; Tietz V; Schenkel J; Heuschmann PU
Cerebrovasc Dis; 2008; 26(2):171-7. PubMed ID: 18628615
[TBL] [Abstract][Full Text] [Related]
15. Antithrombotic management of ischaemic stroke and transient ischaemic attack in China: a consecutive cross-sectional survey.
Wang YL; Wu D; Nguyen-Huynh MN; Zhou Y; Wang CX; Zhao XQ; Liao XL; Liu LP; Wang YJ;
Clin Exp Pharmacol Physiol; 2010 Aug; 37(8):775-81. PubMed ID: 20456429
[TBL] [Abstract][Full Text] [Related]
16. Management and outcomes of transient ischemic attacks in Ontario.
Gladstone DJ; Kapral MK; Fang J; Laupacis A; Tu JV
CMAJ; 2004 Mar; 170(7):1099-104. PubMed ID: 15051693
[TBL] [Abstract][Full Text] [Related]
17. Understanding of medications and associations with adherence, unmet needs, and perceived control of risk factors at two years post-stroke.
Dalli LL; Andrew NE; Kim J; Cadilhac DA; Sanfilippo FM; Thrift AG; Nelson MR; Lannin NA; Olaiya MT; Ryan OF; Booth B; Gall S; Kilkenny MF;
Res Social Adm Pharm; 2022 Sep; 18(9):3542-3549. PubMed ID: 35093283
[TBL] [Abstract][Full Text] [Related]
18. Antithrombotic and interventional treatment options in cardioembolic transient ischaemic attack and ischaemic stroke.
McCabe DJ; Rakhit RD
J Neurol Neurosurg Psychiatry; 2007 Jan; 78(1):14-24. PubMed ID: 17172564
[TBL] [Abstract][Full Text] [Related]
19. Prescription of antithrombotic therapy in older patients hospitalized for transient ischemic attack and ischemic stroke: the GIFA study.
Volpato S; Maraldi C; Blè A; Ranzini M; Rita Atti A; Dominguez LJ; Barbagallo M; Fellin R; Zuliani G;
Stroke; 2004 Apr; 35(4):913-7. PubMed ID: 15001787
[TBL] [Abstract][Full Text] [Related]
20. Preventing strokes: the assessment and management of people with transient ischaemic attack.
Gommans J; Barber PA; Fink J
N Z Med J; 2009 Apr; 122(1293):3556. PubMed ID: 19448791
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
